KEYPAD
21 Dec 2020
ANZUP1601
ACTRN12618000132246
Denosumab and Pembrolizumab in clear cell renal carcinoma
Merck Sharp & Dohme Corp.
Cancer Type | Kidney |
---|---|
Trial Type | Treatment |
Phase | Phase II |
Age Range | 18 years and older |
Sex | All |
Tumour Stream | - |
Cancer Stage | All stages |
Anticipated Start Date | 2017-12-12 |
Anticipated End Date | 2022-12-31 |
Hospital | Flinders Medical Centre |
---|---|
Clinical Trial Coordinator | Alison Richards |
Alison.Richards@sa.gov.au | |
Phone | 08 8206 4835 |
Principal Investigator | Dr Ganessan Kichenadasse |
Recruitment Status | Recruiting |
Keep up to date with the latest news and breakthroughs